Wejdan Bagais joins Ethics Talk to discuss her article, coauthored with Matt Christian: “Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains?”  Recorded January 31, 2024.  Read the full article for free at <a href= "https://journalofethics.ama-assn.org/article/which-data-analytics-tool-should-we-use-evaluate-risk-upstream-drug-supply-chains/2024-04"> JournalofEthics.org</a>

Wejdan Bagais joins Ethics Talk to discuss her article, coauthored with Matt Christian: “Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains?” Recorded January 31, 2024. Read the full article for free at JournalofEthics.org

Wejdan Bagais joins Ethics Talk to discuss her article, coauthored with Matt Christian: “Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains?”&nbsp; Recorded January 31, 2024.&nbsp; Read the full article for free at <a href="https://journalofethics.ama-assn.org/article/which-data-analytics-tool-should-we-use-evaluate-risk-upstream-drug-supply-chains/2024-04" rel="noopener noreferrer"> JournalofEthics.org</a>

Author Interview: “Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains?”

High-stakes ethics decisions are common in health care. What should you do? Each month, the AMA Journal of Ethics’ podcast, Ethics Talk, features interviews with influential experts and leaders on a wide range of cultural, historical, legal, and social topics in health care ethics. We sort through interesting, important, and difficult questions, talk about how to weigh competing values, and offer strategies for navigating real world tough cases.

Share Author Interview: “Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains?”

Sign up to save your podcasts

Author Interview: “Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains?”

Author Interview: “Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains?”